Hinge Health IPO Date, Price, Terms, and Performance
This page contains links to our partners. We may be compensated when a link is clicked. Read the disclosures to learn more.
Explore opportunities to invest in the Hinge Health IPO. The IPO date was Thursday, May 22nd. Hinge Health will trade on the NYSE under the stock symbol “HNGE”. The IPO price is $32 per share. It started traded at 1:05 pm ET. The stock opened a $39.25 per share.
The S-1 IPO filing went live on March 10th and amended on May 13th (see below).
Table of Contents
Notable Hinge Health News
05/21/2025: Hinge Health IPO Prices at $32 per share
05/13/2025: Hinge Health IPO Terms Set
05/05/2025: Hinge Health Updates S-1; Q1 Revenue Up 50%
05/05/2025: From ‘Cockroach Award’ to the Big Board
Older news…
About Hinge Health
Hinge Health is a digital clinic that provides online-delivered physical therapy for muscle and joint pain.
The company was founded in 2014 by Daniel Perez and Gabriel Mecklenburg after both experiencing traumatic injuries requiring musculoskeletal (MSK) rehabilitation.
Its products and services revolve around digital physical therapy and MSK care solutions, using wearable sensors, AI-driven coaching, and virtual physical therapists to help patients manage chronic pain, recover from injuries, and reduce the need for opioid-based pain relief.
The personalized exercise therapy programs and one-on-one coaching for back and joint pain are provided through an app-based platform for employers and health plans, addressing shortages and high costs of in-person physical therapy appointments.
Headquartered in San Francisco, California, Hinge Health has become a leader in the digital MSK health space, serving millions of members across the U.S.
It faces competition from other digital health startups like Sword Health, Kaia Health, and traditional physical therapy facilities.
Here is a recent podcast episode on the upcoming Hinge Health IPO:
IPO Terms
- IPO Date: Thursday, May 22nd, 2025
- Opening Trade: $39.25
- Opening Trade Time: 1:05 pm ET
- Stock Symbol: “HNGE”
- Exchange: NYSE
- Common Stock Offered: 13,666,000 shares
- IPO Valuation: ~$3 billion
- Raise: $437 million
- IPO Price: $32
- Lead Underwriters: Morgan Stanley, Barclays, B of A
- IPO Roadshow
Hinge Health S-1 Filing
Here is the May 13th amended version of the Hinge Health S-1 filing:
Get the Hinge Health S-1 filing on the SEC website.
Ownership
Hinge Health is a venture-backed private company. Equity stakeholders include the founders, employees, and venture capital firms.
The latest funding round raised $400 million in October 2021. The company has raised more than $800 million in private funding since its founding in 2014.
Prominent venture capital investors include Coatue, Tiger Global, Bessemer, Atomico, Leading Edge Capital, Insight Partners, Quadrille Capital, IP Group, Alkeon, Whale Rock, and Heuristic Capital.
Funding Rounds
| Round | Date | Est. Valuation | Raise Amount | Price |
|---|---|---|---|---|
| Series E | 10/27/21 | $6.20B | $400.00M | $ 77.46 |
| Series D | 01/05/21 | $3.00B | $300.00M | $ 43.72 |
| Series C | 02/03/20 | $435.90M | $90.00M | $ 7.31 |
| Series B | 08/08/18 | $90.00M | $26.00M | $ 2.26 |
| Series A | 07/23/17 | $26.40M | $9.57M | $ 1.03 |
| Source: Caplight |
Valuation
The amended IPO filing has given us an estimated market cap of $2.5 to $3 billion (the final market cap depends on the final pricing and underwriters exercising their rights to shares).
The latest confirmed Hinge Health valuation is $6.2 billion based on the October 2021 Series E funding round. However, late 2021 marked peak euphoria in the private fundraising markets.
The valuation as of May 2025 is likely below that value. Private marketplace data from various sources suggest the valuation is less than $3 billion.
Monitor the pre-IPO marketplaces for private share availability headed into the IPO.
IPO Potential
The Hinge Health IPO date will be during the week of May 19th. The date is likely to be the 21st or 22nd. We’ll confirm the final date when it becomes available.
The company released its S-1 IPO filing to the public on March 10th, 2025, suggesting an April 2025 IPO. But tariff uncertainty froze nearly all IPO volume.
The freeze is starting to thaw, and Hinge Health play an important role for the rest of the IPO market.
Morgan Stanley is the lead bookrunner.
How to Invest in Hinge Health Stock
Hinge Health stock is now available for investment.
Even for seasoned investors like many of our readers, accessing private shares or securing an allocation during the IPO is somewhat challenging.
However, waiting to invest can be worthwhile. IPO filings open more financial insights, adding more depth to the public company’s operations each quarter.
IPOs can sometimes give us quick gains, especially for companies in high demand. Timing is critical — being an early investor can lead to lucrative gains when strategically selling during a peak.
For those without IPO access, the post-IPO temptation to grab shares at inflated prices is real. Resist the urge to chase overpriced shares when shares begin trading.
History shows that stock prices often dip after the initial enthusiasm (eventually, below the IPO price), creating attractive price entry points for long-term investors.
Selectivity and patience can distinguish between gains and dead money. The most groundbreaking companies tend to command higher valuations a decade down the line.
So, resist the urge to follow the crowd and focus on the long game for potential lasting wealth.
Frequently Asked Questions (FAQs)
Is Hinge Health Stock Publicly Traded?
Yes. The stock began trading publicly on 05/22/2025.
What is the Hinge Health Stock Symbol?
>The Hinge Health stock symbol will be “HNGE”.
What is the Hinge Health Stock Price?
Hinge Health News Archive
03/10/2025: Hinge Health S-1 Live
04/04/2025: Hinge Health is considering delaying its IPO
04/04/2025: Tariff Turmoil Freezes the U.S. IPO Market
03/07/2025: Hinge Health Weighs IPO Filing as Soon as Next Week
09/26/2024: Hinge Health Hires Morgan Stanley to Lead IPO
10/28/2021: Hinge Health Announces $600 Million Investment
01/08/2021: Hinge Health raises $300M Series D
02/04/2020: Hinge Health closes $90M Series C
08/09/2018: Hinge Health Raises $26 Million
07/24/2017: Hinge Health raises $8M Series A
Conclusion
Hinge Health’s growth and popularity highlight the trending transformation of digital healthcare, which is especially accessible in musculoskeletal care.
As a pioneer in the space, the company has successfully combined AI, virtual therapy, and wearable technology to address a critical gap in traditional physical therapy.
However, its future as a public company will depend on how well it navigates market conditions and investor expectations amid shifting valuations.
IPO volume remains thin, though a Hinge Health IPO could ignite further enthusiasm for health companies to consider public offerings.
The potential IPO presents both risks and opportunities. Early investors may seek liquidity, while new investors will weigh the company’s long-term growth prospects.
Patience and due diligence will be key for those considering an entry point. Whether Hinge Health thrives post-IPO will hinge on its ability to scale profitably, differentiate itself from competitors, and sustain employer and insurer adoption.
For those monitoring the space, the coming months could provide critical insights into whether this digital health leader will continue to redefine the industry or face growing pressures in an evolving market.
Monitor this page for the latest news and insights for the Hinge Health IPO.
Craig Stephens is a former IT professional who left his 19-year consulting career at the IRS to be a full-time finance writer. He started Access IPOs in 2016 to provide a resource for ordinary investors pursuing investment access to IPOs and pre-IPO startups. Craig studied Finance at Michigan State University and lives in Northern Virginia with his wife and three children. Learn more about Craig.
* This is a testimonial in partnership with Fundrise, Hiive, Robinhood, and other affiliate partners. We earn a commission from partner links on AccessIPOs.com. All opinions are my own. If you sign up with one of our partners through certain on this website, Access IPOs will be compensated at no additional cost to the reader. See the full disclosure here. Risk Statement: Access IPOs is for informational purposes only and does not recommend buying or selling any specific pre-IPO company, IPO, or public company. Investing in IPOs and pre-IPO startups involves significant risk. Do not invest in companies based solely on what is included in this article. Only invest in IPOs and pre-IPO companies with money you can afford to lose. Mentions of specific investments should not be construed as financial advice. Conduct personalized research and consider consulting with an investment advisor before investing. Disclosure: The author may hold an active or pending position in this company either directly or indirectly through an investment fund.
